Reprograming osteosarcoma immune landscape by sting and lymphotoxin receptor agonists

Ended Project Grant Awarded Last action

Award ID
W81XWH2211051
Recipient
Awarding agency
Obligated
$818,750

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Baltimore, MD 21218, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Johns Hopkins University was awarded an $818,750 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 2022 through September 2025 to reprogram the immune landscape of osteosarcoma by utilizing STING and lymphotoxin receptor agonists. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine and other health issues. This award will further those goals by investigating immunotherapeutic approaches for osteosarcoma, a type of bone cancer.

Quick answers

Who received award W81XWH2211051?

W81XWH2211051 was awarded to The Johns Hopkins University by Medical Command (Department of the Army) on September 30, 2022.

How much is award W81XWH2211051 worth?

$818,750 has been obligated on W81XWH2211051.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login